Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Pharma
Atara, Pierre Fabre hit a hurdle with Ebvallo in the US
The FDA rejected Atara's biologics license application due to "inspection findings" at a facility run by a third-party manufacturer, the biotech said.
Eric Sagonowsky
Jan 16, 2025 9:36am
Argentina biotech to produce Pfizer's Prevnar 20 in access push
Jan 16, 2025 8:38am
Lyndra enlists Thermo Fisher for research, manufacturing support
Jan 15, 2025 3:36pm
JPM25: CDMO giant Samsung Bio weighs plan to build 6th plant
Jan 15, 2025 9:46am
Aragen snares $100M investment to expand its operations
Jan 14, 2025 7:50am
BioDuro expands peptide production in China with new facility
Jan 13, 2025 9:35am
